We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Snap-on
SNA
$19.4B
| $4.89M | 0.01% |
16,971
+1,204
| +8% | +$312K |
|
702
Weave Communications
WEAV
$587M
| $4.84M | 0.01% |
+435,319
| New | +$2.91M |
|
703
SouthState Bank Corp
SSB
$10.3B
| $4.83M | 0.01% |
73,397
-361
| -0.5% | -$24.1K |
|
704
Energizer
ENR
$1.4B
| $4.8M | 0.01% |
142,984
+88,135
| +161% | +$2.94M |
|
705
Genworth Financial
GNW
$3.78B
| $4.8M | 0.01% |
959,221
-15,404
| -2% | -$84.3K |
|
706
Morgan Stanley
MS
$324B
| $4.79M | 0.01% |
56,084
+7,621
| +16% | +$652K |
|
|
HSII
707
DELISTED
Heidrick & Struggles
HSII
| $4.77M | 0.01% |
180,202
-5,813
| -3% | -$153K |
|
|
THR
708
DELISTED
Thermon Group Holdings
THR
| $4.77M | 0.01% |
179,213
+265
| +0.1% | +$6.15K |
|
709
GSK
GSK
$100B
| $4.76M | 0.01% |
+133,688
| New | +$4.8M |
|
710
Unisys
UIS
$183M
| $4.75M | 0.01% |
1,193,738
+917,993
| +333% | +$3.64M |
|
711
Fidelity National Information Services
FIS
$19.3B
| $4.74M | 0.01% |
86,693
+68,814
| +385% | +$3.79M |
|
712
AvePoint
AVPT
$2.88B
| $4.71M | 0.01% |
818,304
+800,617
| +4,527% | +$4.22M |
|
713
Chord Energy
CHRD
$8.59B
| $4.65M | 0.01% |
30,219
+20,761
| +220% | +$3.01M |
|
714
Marvell Technology
MRVL
$199B
| $4.63M | 0.01% |
77,500
-18,045
| -19% | -$877K |
|
715
AGNC Investment
AGNC
$11.8B
| $4.63M | 0.01% |
457,194
+79,547
| +21% | +$773K |
|
716
BlueLinx
BXC
$604M
| $4.63M | 0.01% |
49,324
+26,906
| +120% | +$2.15M |
|
717
Rush Street Interactive
RSI
$3.01B
| $4.61M | 0.01% |
1,476,201
-35,863
| -2% | -$111K |
|
718
Old National Bancorp
ONB
$9.87B
| $4.6M | 0.01% |
329,977
-16,555
| -5% | -$220K |
|
|
BRSL
719
Brightstar Lottery PLC
BRSL
$1.93B
| $4.59M | 0.01% |
144,087
-213,268
| -60% | -$5.93M |
|
|
EXAS
720
DELISTED
Exact Sciences
EXAS
| $4.57M | 0.01% |
+48,695
| New | +$3.8M |
|
721
Alkermes
ALKS
$7.72B
| $4.55M | 0.01% |
145,332
+24,536
| +20% | +$743K |
|
722
QCR Holdings
QCRH
$1.68B
| $4.53M | 0.01% |
110,444
-235
| -0.2% | -$9.62K |
|
723
Iridium Communications
IRDM
$4.99B
| $4.5M | 0.01% |
72,491
-32,659
| -31% | -$2.02M |
|
724
Red Robin
RRGB
$137M
| $4.46M | 0.01% |
322,128
-5,465
| -2% | -$73.3K |
|
725
Johnson Controls International
JCI
$83.8B
| $4.44M | 0.01% |
65,151
-301,529
| -82% | -$18.5M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.